These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15557156)

  • 41. The fate of low affinity tumor-specific CD8+ T cells in tumor-bearing mice.
    Lyman MA; Nugent CT; Marquardt KL; Biggs JA; Pamer EG; Sherman LA
    J Immunol; 2005 Mar; 174(5):2563-72. PubMed ID: 15728462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. III. Direct correlation between development of syngeneic cytotoxicity and loss of veto activity; implications for the mechanism of veto action.
    Claesson MH; Miller RG
    Scand J Immunol; 1989 Apr; 29(4):493-7. PubMed ID: 2470139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of lymphokine-activated killer cells as mediators of veto and natural suppression.
    Azuma E; Kaplan J
    J Immunol; 1988 Oct; 141(8):2601-6. PubMed ID: 3171179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ly49D engagement on T lymphocytes induces TCR-independent activation and CD8 effector functions that control tumor growth.
    Merck E; Voyle RB; MacDonald HR
    J Immunol; 2009 Jan; 182(1):183-92. PubMed ID: 19109149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.
    Milstein O; Hagin D; Lask A; Reich-Zeliger S; Shezen E; Ophir E; Eidelstein Y; Afik R; Antebi YE; Dustin ML; Reisner Y
    Blood; 2011 Jan; 117(3):1042-52. PubMed ID: 21045195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells.
    Walker PR; Calzascia T; Schnuriger V; Scamuffa N; Saas P; de Tribolet N; Dietrich PY
    J Immunol; 2000 Sep; 165(6):3128-35. PubMed ID: 10975826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple paths for activation of naive CD8+ T cells: CD4-independent help.
    Wang B; Norbury CC; Greenwood R; Bennink JR; Yewdell JW; Frelinger JA
    J Immunol; 2001 Aug; 167(3):1283-9. PubMed ID: 11466344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes.
    Hiruma K; Nakamura H; Henkart PA; Gress RE
    J Exp Med; 1992 Mar; 175(3):863-8. PubMed ID: 1371306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity.
    Sandberg JK; Franksson L; Sundbäck J; Michaelsson J; Petersson M; Achour A; Wallin RP; Sherman NE; Bergman T; Jörnvall H; Hunt DF; Kiessling R; Kärre K
    J Immunol; 2000 Jul; 165(1):25-33. PubMed ID: 10861031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.
    Owens T; Crispe IN
    J Immunol; 1985 Nov; 135(5):2984-9. PubMed ID: 2413108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
    J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.
    Leshem B; Kedar E
    J Exp Med; 1990 Apr; 171(4):1057-71. PubMed ID: 2139097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiself suppressive (veto) activity of responder cells in mixed lymphocyte cultures.
    Claësson MH; Röpke C
    Curr Top Microbiol Immunol; 1986; 126():213-23. PubMed ID: 2941241
    [No Abstract]   [Full Text] [Related]  

  • 55. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
    Cron RQ; Gajewski TF; Sharrow SO; Fitch FW; Matis LA; Bluestone JA
    J Immunol; 1989 Jun; 142(11):3754-62. PubMed ID: 2523934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerance induction by elimination of subsets of self-reactive thymocytes.
    Sponaas AM; Tomlinson PD; Schulz R; Antoniou J; Ize-Iyamu P; Schmitt-Verhulst AM; Mellor AL
    Int Immunol; 1994 Oct; 6(10):1593-604. PubMed ID: 7826949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NK and CTL recognition of a single chain H-2Dd molecule: distinct sites of H-2Dd interact with NK and TCR.
    Chung DH; Dorfman J; Plaksin D; Natarajan K; Belyakov IM; Hunziker R; Berzofsky JA; Yokoyama WM; Mage MG; Margulies DH
    J Immunol; 1999 Oct; 163(7):3699-708. PubMed ID: 10490965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of the mechanism of TCR antagonism using dual-TCR-expressing T cells.
    Yang W; Grey HM
    J Immunol; 2003 May; 170(9):4532-8. PubMed ID: 12707330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
    Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
    J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of functional heterogeneity in the CD8 subset with T cells from T cell receptor-transgenic mice.
    Gaugler B; Schmitt-Verhulst AM; Guimezanes A
    Eur J Immunol; 1993 Aug; 23(8):1851-8. PubMed ID: 8344346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.